Patents by Inventor Roy E. Twyman

Roy E. Twyman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carbamate compounds for use in preventing or treating bipolar disorder
    Publication number: 20020193433
    Abstract: This invention is directed to a method for preventing or treating bipolar disorder comprising administering to a subject in need thereof a therapeutically effective amount of an enantiomer of Formula (I) or enantiomeric mixture wherein one enantiomer of Formula (I) predominates: 1
    Type: Application
    Filed: February 21, 2002
    Publication date: December 19, 2002
    Inventors: Carlos R. Plata-Salaman, Boyu Zhao, Roy E. Twyman, Yong Moon Choi, Robert Gordon
  • CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PSYCHOTIC DISORDERS
    Publication number: 20020165272
    Abstract: This invention is directed to a method for preventing or treating psychotic disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): 1
    Type: Application
    Filed: February 21, 2002
    Publication date: November 7, 2002
    Inventors: Carlos R. Plata-Salaman, Boyu Zhao, Roy E. Twyman
  • Carbamate compounds for use in preventing or treating neurodegenerative disorders
    Publication number: 20020165273
    Abstract: This invention is directed to a method for preventing or treating neurodegenerative disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): 1
    Type: Application
    Filed: February 21, 2002
    Publication date: November 7, 2002
    Inventors: Carlos R. Plata-Salaman, Boyu Zhao, Roy E. Twyman
  • Carbamate compounds for use in the treatment of pain
    Publication number: 20020156127
    Abstract: This invention is directed to a method for the treatment of pain comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): 1
    Type: Application
    Filed: February 21, 2002
    Publication date: October 24, 2002
    Inventors: Carlos R. Plata-Salaman, Boyu Zhao, Roy E. Twyman
  • Carbamate compounds for use in preventing or treating movement disorders
    Publication number: 20020151585
    Abstract: This invention is directed to a method for preventing or treating movement disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): 1
    Type: Application
    Filed: February 21, 2002
    Publication date: October 17, 2002
    Inventors: Carlos R. Plata-Salaman, Boyu Zhao, Roy E. Twyman
  • Carbamate compounds for use in preventing or treating anxiety disorders
    Publication number: 20020143053
    Abstract: This invention is directed to a method for preventing or treating anxiety disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): 1
    Type: Application
    Filed: February 21, 2002
    Publication date: October 3, 2002
    Inventors: Carlos R. Plata-Salaman, Boyu Zhao, Roy E. Twyman
  • Autoantibodies to neurotransmitter receptors
    Patent number: 6010854
    Abstract: A peptide containing 24 amino acid residues that binds to anti-neuronal-glutamate-receptor autoantibodies associated with Rasmussen's encephalitis and that blocks activation of the GluR3 subunit is described. Methods of making the peptide and treating Rasmussen's encephalitis are also disclosed. Autoantibodies to other glutamate receptor subunits are associated with paraneoplastic neurodegenerative disease, amyotrophic lateral sclerosis, and neurodegenerative disease of unknown diagnosis. Methods of screening patients and of monitoring patients being treated for these disorders and syndromes are further described.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: January 4, 2000
    Assignee: University of Utah Research Foundation
    Inventors: Scott W. Rogers, Lorise C. Gahring, Roy E. Twyman
  • Peptide for blocking autoantibody-evoked activation of glutamate receptor type 3 (GLUR3)
    Patent number: 5731410
    Abstract: A peptide containing 24 amino acid residues that binds to anti-neuronal-glutamate-receptor autoantibodies associated with Rasmussen's encephalitis and that blocks activation of the GluR3 subunit is described. Methods of making the peptide and treating Rasmussen's encephalitis are also disclosed. Autoantibodies to other glutamate receptor subunits are associated with paraneoplastic neurodegenerative disease, amyotrophic lateral sclerosis, and neurodegenerative disease of unknown diagnosis. Methods of screening patients and of monitoring patients being treated for these disorders and syndromes are further described.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: March 24, 1998
    Assignee: University of Utah Research Foundation
    Inventors: Scott W. Rogers, Lorise C. Gahring, Roy E. Twyman